DWA
GSK icon

Dorsey Wright & Associates’s GSK GSK Stock Holding History

Dorsey Wright & Associates’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.71M Sell
32,575
-13,118
-29% -$694K 0.29% 76
2026
Q1 		$2.52M Buy
+45,693
New +$2.48M 0.31% 80

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Dorsey Wright & Associates's GSK Position: Q2 2026 in Review

Dorsey Wright & Associates reduced its GSK (GSK) stake by 29% in Q2 2026, selling an estimated $694K and leaving 32,575 shares worth $1.71M. The position accounts for 0.29% of the portfolio, ranked #76.

Dorsey Wright & Associates first reported a position in GSK in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.52M in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Dorsey Wright & Associates held 32,575 shares of GSK worth $1.71M as of Q2 2026.
  • Dorsey Wright & Associates sold 13,118 GSK shares in Q2 2026, an estimated $694K.
  • GSK made up 0.29% of Dorsey Wright & Associates's portfolio in Q2 2026, its #76 holding.
  • Dorsey Wright & Associates first reported a position in GSK in Q1 2026 and has held it in 2 quarters since.
  • Dorsey Wright & Associates's GSK position peaked at $2.52M in Q1 2026.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Dorsey Wright & Associates's 13F filing for Q2 2026, filed 6 Aug 2026.